US Stock MarketDetailed Quotes

KNSA Kiniksa Pharmaceuticals International

Watchlist
  • 23.090
  • -0.270-1.16%
Close Mar 28 16:00 ET
  • 23.090
  • 0.0000.00%
Post 17:42 ET
1.68BMarket Cap-38.48P/E (TTM)

Kiniksa Pharmaceuticals International Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
93.14%25.69M
333.99%18.77M
-113.16%-2.24M
238.07%5.17M
193.44%3.99M
129.05%13.3M
137.36%4.33M
-72.63%16.99M
52.16%-3.74M
88.42%-4.27M
Net income from continuing operations
-406.68%-43.19M
-135.22%-8.89M
8.39%-12.69M
-126.10%-3.91M
-44.29%-17.7M
-92.32%14.08M
465.73%25.24M
-106.18%-13.86M
174.93%14.97M
51.33%-12.27M
Operating gains losses
-113.41%-24K
--0
--0
----
----
442.42%179K
-60.00%4K
--0
--0
--175K
Depreciation and amortization
-27.60%1.7M
-25.93%400K
-33.83%399K
-28.57%430K
-21.81%466K
-2.54%2.34M
-10.30%540K
22.31%603K
-7.53%602K
-9.15%596K
Deferred tax
124.07%8.13M
87.70%-3.16M
-135.37%-3.64M
154.36%10.57M
305.29%4.37M
81.78%-33.79M
-7,487.64%-25.71M
105.54%10.29M
---19.44M
--1.08M
Other non cash items
2.69%3.14M
4.07%767K
6.65%754K
8.71%836K
-7.37%779K
0.43%3.05M
-6.47%737K
-8.42%707K
3.08%769K
14.42%841K
Change In working capital
1,737.70%24.81M
618.48%20.54M
-49.12%5.6M
-66.19%-9.91M
3,199.23%8.58M
105.98%1.35M
83.46%-3.96M
-33.76%11.01M
-250.05%-5.96M
101.35%260K
-Change in receivables
-2,053.47%-20.46M
7.62%-16.84M
-120.53%-4.44M
74.13%-4.46M
-59.11%5.27M
94.18%-950K
-99.03%-18.23M
744.85%21.61M
-179.63%-17.23M
150.65%12.89M
-Change in inventory
149.96%4.76M
141.81%2.32M
480.18%6.18M
-1,322.14%-7.58M
310.51%3.84M
46.87%-9.52M
20.62%-5.54M
-130.69%-1.63M
92.04%-533K
80.88%-1.83M
-Change in prepaid assets
61.65%-2.71M
56.01%13.8M
50.01%-6.99M
-1,971.23%-13.27M
242.37%3.75M
-83.18%-7.07M
81.70%8.85M
-971.80%-13.99M
120.32%709K
33.01%-2.63M
-Change in payables and accrued expense
116.48%37.42M
-62.39%4.71M
46.85%11.71M
46.12%20.38M
103.63%623K
644.49%17.29M
374.42%12.52M
768.41%7.97M
304.10%13.95M
-406.34%-17.16M
-Change in other current assets
-312.37%-9.74M
-279.52%-2.52M
---10K
-4,165.56%-3.84M
-202.88%-3.36M
72.72%4.58M
630.57%1.41M
--0
-155.21%-90K
18.62%3.27M
-Change in other current liabilities
-23.97%-4.02M
-16.90%-927K
-18.28%-841K
-25.41%-997K
-32.98%-1.25M
-125.45%-3.24M
-2.85%-793K
-191.27%-711K
1.12%-795K
-46.88%-943K
-Change in other working capital
7,390.42%19.55M
1,019.54%20M
99.96%-1K
92.16%-155K
-104.42%-294K
-97.83%261K
84.78%-2.18M
-115.70%-2.24M
---1.98M
-44.52%6.66M
Cash from discontinued investing activities
Operating cash flow
93.14%25.69M
333.99%18.77M
-113.16%-2.24M
238.07%5.17M
193.44%3.99M
129.05%13.3M
137.36%4.33M
-72.63%16.99M
52.16%-3.74M
88.42%-4.27M
Investing cash flow
Cash flow from continuing investing activities
227.46%37.67M
538.38%65.29M
48.29%-6.35M
-231.70%-46.8M
167.31%25.52M
-265.90%-29.56M
65.09%-14.89M
-164.48%-12.28M
-7.14%35.53M
-66.88%-37.92M
Net PPE purchase and sale
-93.85%-252K
-244.64%-193K
--0
173.53%25K
-250.00%-84K
-828.57%-130K
-233.33%-56K
50.00%-16K
-41.67%-34K
---24K
Net investment purchase and sale
228.87%37.92M
541.34%65.49M
48.23%-6.35M
-231.64%-46.82M
167.57%25.61M
-264.92%-29.43M
65.25%-14.84M
-164.29%-12.26M
-7.11%35.57M
-66.77%-37.9M
Cash from discontinued investing activities
Investing cash flow
227.46%37.67M
538.38%65.29M
48.29%-6.35M
-231.70%-46.8M
167.31%25.52M
-265.90%-29.56M
65.09%-14.89M
-164.48%-12.28M
-7.14%35.53M
-66.88%-37.92M
Financing cash flow
Cash flow from continuing financing activities
720.47%12.27M
208.20%2.14M
1,111.78%6.69M
-212.66%-178K
3,914.44%3.61M
-40.58%1.5M
-41.60%695K
52.91%552K
-70.85%158K
-78.72%90K
Net common stock issuance
-125.93%-4.98M
-120.61%-578K
-145.43%-2.71M
-213.37%-1.31M
9.29%-381K
-144.84%-2.21M
-162.00%-262K
-431.25%-1.11M
-1,645.83%-419K
26.19%-420K
Proceeds from stock option exercised by employees
366.09%17.25M
184.22%2.72M
467.35%9.4M
96.71%1.14M
683.14%3.99M
8.31%3.7M
-25.81%957K
191.21%1.66M
1.94%577K
-48.59%510K
Cash from discontinued financing activities
Financing cash flow
720.47%12.27M
208.20%2.14M
1,111.78%6.69M
-212.66%-178K
3,914.44%3.61M
-40.58%1.5M
-41.60%695K
52.91%552K
-70.85%158K
-78.72%90K
Net cash flow
Beginning cash position
-12.03%107.95M
-17.36%97.38M
-11.81%99.27M
75.00%141.08M
-12.03%107.95M
0.20%122.72M
-32.96%117.83M
19.36%112.57M
27.31%80.62M
0.20%122.72M
Current changes in cash
612.34%75.63M
973.05%86.21M
-136.02%-1.9M
-230.86%-41.81M
178.68%33.12M
-6,124.90%-14.76M
81.39%-9.87M
-93.54%5.26M
3.12%31.95M
28.83%-42.1M
End cash Position
70.05%183.58M
70.05%183.58M
-17.36%97.38M
-11.81%99.27M
75.00%141.08M
-12.03%107.95M
-12.03%107.95M
-32.96%117.83M
19.36%112.57M
27.31%80.62M
Free cash flow
92.94%25.41M
335.16%18.58M
-113.18%-2.24M
236.83%5.17M
190.96%3.9M
130.99%13.17M
136.98%4.27M
-72.64%16.97M
52.42%-3.78M
88.35%-4.29M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 93.14%25.69M333.99%18.77M-113.16%-2.24M238.07%5.17M193.44%3.99M129.05%13.3M137.36%4.33M-72.63%16.99M52.16%-3.74M88.42%-4.27M
Net income from continuing operations -406.68%-43.19M-135.22%-8.89M8.39%-12.69M-126.10%-3.91M-44.29%-17.7M-92.32%14.08M465.73%25.24M-106.18%-13.86M174.93%14.97M51.33%-12.27M
Operating gains losses -113.41%-24K--0--0--------442.42%179K-60.00%4K--0--0--175K
Depreciation and amortization -27.60%1.7M-25.93%400K-33.83%399K-28.57%430K-21.81%466K-2.54%2.34M-10.30%540K22.31%603K-7.53%602K-9.15%596K
Deferred tax 124.07%8.13M87.70%-3.16M-135.37%-3.64M154.36%10.57M305.29%4.37M81.78%-33.79M-7,487.64%-25.71M105.54%10.29M---19.44M--1.08M
Other non cash items 2.69%3.14M4.07%767K6.65%754K8.71%836K-7.37%779K0.43%3.05M-6.47%737K-8.42%707K3.08%769K14.42%841K
Change In working capital 1,737.70%24.81M618.48%20.54M-49.12%5.6M-66.19%-9.91M3,199.23%8.58M105.98%1.35M83.46%-3.96M-33.76%11.01M-250.05%-5.96M101.35%260K
-Change in receivables -2,053.47%-20.46M7.62%-16.84M-120.53%-4.44M74.13%-4.46M-59.11%5.27M94.18%-950K-99.03%-18.23M744.85%21.61M-179.63%-17.23M150.65%12.89M
-Change in inventory 149.96%4.76M141.81%2.32M480.18%6.18M-1,322.14%-7.58M310.51%3.84M46.87%-9.52M20.62%-5.54M-130.69%-1.63M92.04%-533K80.88%-1.83M
-Change in prepaid assets 61.65%-2.71M56.01%13.8M50.01%-6.99M-1,971.23%-13.27M242.37%3.75M-83.18%-7.07M81.70%8.85M-971.80%-13.99M120.32%709K33.01%-2.63M
-Change in payables and accrued expense 116.48%37.42M-62.39%4.71M46.85%11.71M46.12%20.38M103.63%623K644.49%17.29M374.42%12.52M768.41%7.97M304.10%13.95M-406.34%-17.16M
-Change in other current assets -312.37%-9.74M-279.52%-2.52M---10K-4,165.56%-3.84M-202.88%-3.36M72.72%4.58M630.57%1.41M--0-155.21%-90K18.62%3.27M
-Change in other current liabilities -23.97%-4.02M-16.90%-927K-18.28%-841K-25.41%-997K-32.98%-1.25M-125.45%-3.24M-2.85%-793K-191.27%-711K1.12%-795K-46.88%-943K
-Change in other working capital 7,390.42%19.55M1,019.54%20M99.96%-1K92.16%-155K-104.42%-294K-97.83%261K84.78%-2.18M-115.70%-2.24M---1.98M-44.52%6.66M
Cash from discontinued investing activities
Operating cash flow 93.14%25.69M333.99%18.77M-113.16%-2.24M238.07%5.17M193.44%3.99M129.05%13.3M137.36%4.33M-72.63%16.99M52.16%-3.74M88.42%-4.27M
Investing cash flow
Cash flow from continuing investing activities 227.46%37.67M538.38%65.29M48.29%-6.35M-231.70%-46.8M167.31%25.52M-265.90%-29.56M65.09%-14.89M-164.48%-12.28M-7.14%35.53M-66.88%-37.92M
Net PPE purchase and sale -93.85%-252K-244.64%-193K--0173.53%25K-250.00%-84K-828.57%-130K-233.33%-56K50.00%-16K-41.67%-34K---24K
Net investment purchase and sale 228.87%37.92M541.34%65.49M48.23%-6.35M-231.64%-46.82M167.57%25.61M-264.92%-29.43M65.25%-14.84M-164.29%-12.26M-7.11%35.57M-66.77%-37.9M
Cash from discontinued investing activities
Investing cash flow 227.46%37.67M538.38%65.29M48.29%-6.35M-231.70%-46.8M167.31%25.52M-265.90%-29.56M65.09%-14.89M-164.48%-12.28M-7.14%35.53M-66.88%-37.92M
Financing cash flow
Cash flow from continuing financing activities 720.47%12.27M208.20%2.14M1,111.78%6.69M-212.66%-178K3,914.44%3.61M-40.58%1.5M-41.60%695K52.91%552K-70.85%158K-78.72%90K
Net common stock issuance -125.93%-4.98M-120.61%-578K-145.43%-2.71M-213.37%-1.31M9.29%-381K-144.84%-2.21M-162.00%-262K-431.25%-1.11M-1,645.83%-419K26.19%-420K
Proceeds from stock option exercised by employees 366.09%17.25M184.22%2.72M467.35%9.4M96.71%1.14M683.14%3.99M8.31%3.7M-25.81%957K191.21%1.66M1.94%577K-48.59%510K
Cash from discontinued financing activities
Financing cash flow 720.47%12.27M208.20%2.14M1,111.78%6.69M-212.66%-178K3,914.44%3.61M-40.58%1.5M-41.60%695K52.91%552K-70.85%158K-78.72%90K
Net cash flow
Beginning cash position -12.03%107.95M-17.36%97.38M-11.81%99.27M75.00%141.08M-12.03%107.95M0.20%122.72M-32.96%117.83M19.36%112.57M27.31%80.62M0.20%122.72M
Current changes in cash 612.34%75.63M973.05%86.21M-136.02%-1.9M-230.86%-41.81M178.68%33.12M-6,124.90%-14.76M81.39%-9.87M-93.54%5.26M3.12%31.95M28.83%-42.1M
End cash Position 70.05%183.58M70.05%183.58M-17.36%97.38M-11.81%99.27M75.00%141.08M-12.03%107.95M-12.03%107.95M-32.96%117.83M19.36%112.57M27.31%80.62M
Free cash flow 92.94%25.41M335.16%18.58M-113.18%-2.24M236.83%5.17M190.96%3.9M130.99%13.17M136.98%4.27M-72.64%16.97M52.42%-3.78M88.35%-4.29M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
-0.07%
Vale SA
VALE
-1.28%
NVIDIA
NVDA
-1.58%
Ecopetrol
EC
-1.64%
Taylor Morrison Home
TMHC
-2.11%

Unlock the Full List